FDA Grants Breakthrough Device Designation to ORTHOSON's Bio

This designation assures enhanced FDA cooperation and priority regulatory review of the company's novel medical solution for back pain due to degenerative disc diseaseOXFORD, England--(BUSINESS WIRE)--ORTHOSON, a medtech innovator developing a portfolio of novel treatments for back pain, today announced that its Bio...

Related Keywords

United Kingdom , United States , Mey Saied , University Of Sheffield , Drug Administration , Sheffield Hallam University , Breakthrough Devices Program , Breakthrough Device Program , University Of Oxford Institute Biomedical Engineering , Bio Structural Gel , Breakthrough Device Designation , Structural Gel , Biomedical Engineering , Ken Reali , Devices Program , Rich Simmonds , Seriesb Fundraising , Sheffield Hallam ,